Frontlight ResearchEarly access
Trial site
Institut de Cancérologie de l'Ouest - site de Saint Herblain
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- ARCAGY/ GINECO GROUP1 trial
- Essa Pharma Inc.1 trial
- Federation Francophone de Cancerologie Digestive1 trial
- Groupe Oncologie Radiotherapie Tete Cou1 trial
- Gustave Roussy, Cancer Campus, Grand Paris1 trial
- and 1 more
Running trials
Active, not recruiting
Recruiting
Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026